Moderna's Billion-Dollar mRNA Story Is Just Getting Started

The coronavirus vaccine is Moderna's first commercialized product. So Moderna started its story as a commercial-stage company with a bang. We can't expect every potential product to generate as much revenue as a product used to fight a pandemic. But that doesn't mean blockbuster revenue is over. In fact, the following two charts indicate Moderna is at the beginning of its growth story.